MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date

Thursday, June 23, 2016

12:00pm-1:30pm
Correlation between Parkinson’s disease and malignant tumors

E. Binaghi, M.M. Mascia, P. Solla, M. Meloni, R. Farris, D. Ciaccio, G. Orofino, F. Marrosu, A. Cannas (Cagliari, Italy)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Coupling between visual information and body sway in people with Parkinson’s disease

C.F. Cruz, L.A.O.A. Nóbrega, E. Okamoto, M.E.P. Piemonte, J.A. Barela (São Paulo, Brazil)

Other  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Creatine for patients with Parkinson’s disease: A meta-analysis

A. Attia, H. Ahmed, M. Morsi, K. Awad, M. Elnenny, E. Ghanem, A. Negida (Cairo, Egypt)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Creativity related to dopaminergic treatment. A multicenter study

P.J. Garcia Ruiz, J.C. Martinez Castrillo, L. Vela (Madrid, Spain)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Creutzfeldt-Jakob disease presenting predominantly with movement disorder: A case report

A.A. Sann, M.M. Zaw, T.L. Choie (Yangon, Myanmar)

Other  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Critical path for Parkinson’s, I: Data sharing and regulatory science in catalyzing innovation for Parkinson’s disease

K. Romero, D. Burn, M. Hu, A. Yarnell, C. Williams Gray, K. Marek, D. Grosset, M. Sutherland, M. Isaac, A. Bhattaram, V. Sinha, M.F. Gordon, P. Muglia, L. Slicker, W. Hirst, M. Facheris, J. Posener, M. Bani, B. Corrigan, R. Schindler, K. Tsai, T. Nicholas, J. Cedarbaum, J. Gallagher, S. Ford, E. Avilex, V. Kern, S. Arneric, D. Stephenson, A. Roach (Tucson, AZ, USA)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
CSF level of chromogranin A in amyotrophic lateral sclerosis

M. Kaiserova, P. Otruba, K. Mensikova, Z. Grambalova, H. Prikrylova Vranova, J. Mares, D. Stejskal, P. Kanovsky (Olomouc, Czech Republic)

Other  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Curcumin supplementation improves motor dysfunction in lipopolysaccharide induced Parkinon’s disease model: Possible biochemical, neurochemical and immunohistochemical alterations in rats

N. Sharma, B. Nehru (Chandigarh, India)

Neuropharmacology  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Day case initiation of subcutaneous apomorphine in people with Parkinson’s disease: A retrospective analysis from a UK teaching hospital

K. Nalamada, J. Cosgrove, P. Duggan-Carter, S. Jamieson, J. Alty (Leeds, United Kingdom)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
DBS outcomes in a mixed cohort of dystonia: A single center experience

O. Saeed, I. Haq, S.B. Tatter, A.W. Laxton, T. Wilson, M. Siddiqui (Winston Salem, NC, USA)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
  • «Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 53
  • Next Page»

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley